Ondine Biomedical Inc.
OBIMF
$0.25
$0.0847.06%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.15M | -19.12M | -17.12M | -15.42M | -13.92M |
| Total Depreciation and Amortization | 422.00K | 422.00K | 423.40K | 415.20K | 412.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 921.10K | 877.30K | 836.80K | 826.00K | 822.60K |
| Change in Net Operating Assets | 2.72M | 2.63M | 2.55M | 1.96M | 1.38M |
| Cash from Operations | -17.09M | -15.19M | -13.31M | -12.22M | -11.30M |
| Capital Expenditure | -84.30K | -50.90K | -17.10K | -12.10K | -7.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -84.30K | -50.90K | -17.10K | -12.10K | -7.40K |
| Total Debt Issued | -- | 826.00K | 1.65M | 1.65M | 1.65M |
| Total Debt Repaid | -380.00K | -669.00K | -958.00K | -961.00K | -964.00K |
| Issuance of Common Stock | 25.98M | 24.34M | 22.69M | 22.84M | 22.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.38M | -1.39M | -1.40M | -1.67M | -1.93M |
| Cash from Financing | 17.41M | 16.59M | 15.83M | 15.77M | 15.80M |
| Foreign Exchange rate Adjustments | 274.90K | 429.80K | 589.20K | 492.20K | 399.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 513.70K | 1.78M | 3.10M | 4.03M | 4.89M |